학술논문

Caspr2 autoantibody-associated Morvan syndrome predating thymoma relapse by 30 months.
Document Type
Article
Source
Lung Cancer (01695002). Mar2021, Vol. 153, p117-119. 3p.
Subject
*THYMOMA
*CENTRAL nervous system
*SYNDROMES
*CANCER relapse
*DIAGNOSIS
*POTASSIUM channels
Language
ISSN
0169-5002
Abstract
• Morvan syndrome is a very rare autoimmune disorder, most commonly associated with thymoma, alhough present in <1% of cases. • The triade of CNS involvement, autonomic dysfunction and peripheral nerve hyperexcitability is pathgonomic for Morvan syndrome. • Morvan syndrome is associated with Caspr2 autoantibodies directed to thalamic and striatal neurons. • Paraneoplastic syndromes may predate diagnosis or relapse of cancer by years. Morvan's syndrome (MoS) is a rare autoimmune disorder characterized by central nervous system involvement, autonomic dysfunction and peripheral nerve hyperexcitability. MoS is believed to be caused by autoantibodies targeting contactin-associated protein 2 (Caspr2), a subunit of the neuronal voltage-gated potassium channel (VGKC) complex, usually in association with thymoma, less commonly with other malignancies. This case highlights an exceptional case of severe sleep disturbances and behavioural changes due to MoS, in a patient who would present with and be treated successfully for a second relapse of thymoma 30 months later. Originally he suffered from ocular myasthenia, another autoimmune disorder, which led to diagnosis of his original thymoma and first relapse. [ABSTRACT FROM AUTHOR]